On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitors

被引：12
|
作者：
Hinke, SA
McIntosh, CHS
Hoffmann, T
Kuhn-Wache, K
Wagner, L
Bär, J
Manhart, S
Wermann, M
Pederson, RA
Demuth, HU
机构：
[1] Probiodrug AG, D-06120 Halle Saale, Germany
[2] Univ British Columbia, Dept Physiol, Vancouver, BC V5Z 1M9, Canada
来源：
DIABETES CARE | 2002年 / 25卷 / 08期
关键词：
D O I：
10.2337/diacare.25.8.1490-b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1490 / 1491
页数：2
相关论文
共 50 条
  • [31] Synthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetes
    Singh, Anand-Krishna
    Jatwa, Rameshwar
    Purohit, Ashok
    Ram, Heera
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2017, 19 (10) : 1036 - 1045
  • [32] Novel inhibitors of dipeptidyl-peptidase IV.
    Boehringer, MP
    Hennig, M
    Kuhn, B
    Loeffler, BM
    Luebbers, T
    Mattei, P
    Narquizian, R
    Peters, JU
    Wessel, HP
    Wyss, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U945 - U945
  • [33] JANUVIA® and beyond: Selective dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
    Weber, Ann E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [34] Synthesis and evaluation of fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors for the treatment of diabetes.
    Caldwell, CG
    Chen, P
    He, JF
    Parmee, ER
    Leiting, B
    Marsilio, F
    Patel, RA
    Wu, JK
    Eiermann, GJ
    Hickey, GJ
    McCann, ME
    He, HB
    Lyons, KA
    Fisher, MH
    Wyvratt, MJ
    Thornberry, NA
    Weber, AE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U17 - U18
  • [35] Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?
    Juillerat-Jeanneret, Lucienne
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2197 - 2212
  • [36] Substituted piperazines as novel dipeptidyl peptidase IV inhibitors
    Brockunier, LL
    He, JF
    Colwell, LF
    Habulihaz, B
    He, HB
    Leiting, B
    Lyons, KA
    Marsilio, F
    Patel, RA
    Teffera, Y
    Wu, JK
    Thornberry, NA
    Ann, AE
    Parmee, ER
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (18) : 4763 - 4766
  • [37] Dipeptidyl Peptidase IV Inhibitors and Ischemic Myocardial Injury
    Yoon, Alyssa H.
    Ye, Yumei
    Birnbaum, Yochai
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (05) : 417 - 425
  • [38] Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis
    Wu, D.
    Li, L.
    Liu, C.
    DIABETES OBESITY & METABOLISM, 2014, 16 (01): : 30 - 37
  • [39] Vascular Protection with Dipeptidyl Peptidase-IV inhibitors in Diabetes: Experimental and Clinical Therapeutics
    Ahmed, Heba A.
    May, Dianne W.
    Fagan, Susan C.
    Segar, Lakshman
    PHARMACOTHERAPY, 2015, 35 (03): : 277 - 297
  • [40] Inhibitors of dipeptidyl peptidase IV:: a novel approach for the prevention and treatment of Type 2 diabetes?
    Deacon, CF
    Ahrén, B
    Holst, JJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (09) : 1091 - 1102
12345